Effectiveness of Tyrosine Kinase Inhibitors on Uncommon Epidermal Growth Factor 
Receptor Mutations in Non-small Cell Lung Cancer

by Xue YANG, Hanxiao CHEN, Hong ZHANG, Jianchun DUAN, Tongtong AN, Jun ZHAO, Minglei ZHUO, Meina WU, Jie WANG
Published 2015-08-01

A Review of EGFR-TKIs Therapy of Non-small Cell Lung Cancer
with Uncommon EGFR Mutations

by Wenxing DU, Yang WO, Tong LU, Yuanyong WANG, Wenjie JIAO
Published 2019-09-01

Successful Treatment of Afatinib-Refractory Non-Small Cell Lung Cancer with Uncommon Complex EGFR Mutations Using Pembrolizumab: A Case Report

by Yuri Taniguchi, Momoko Yamamoto, Hiroaki Ikushima, Sayaka Ohara, Hideyuki Takeshima, Toshio Sakatani, Kazuhiro Usui
Published 2019-07-01

EGFR Exon 18 Mutations in Advanced Non-Small Cell Lung Cancer: A Real-World Study on Diverse Treatment Patterns and Clinical Outcomes

by Haiyan Xu, Guangjian Yang, Weihua Li, Junling Li, Xuezhi Hao, Puyuan Xing, Yaning Yang, Yan Wang
Published 2021-09-01

Efficacy of Osimertinib in NSCLC Harboring Uncommon EGFR L861Q and Concurrent Mutations: Case Report and Literature Review

by Ruiting Lin, Ruilian Chen, Zhiqiang Chen, Leihao Hu, Wei Guo, Zexin Zhang, Lizhu Lin, Hanrui Chen
Published 2021-09-01

Limited effect of afatinib in a non‐small cell lung cancer patient harboring an epidermal growth factor receptor K860I missense mutation: A case report

by Tomoki Tamura, Keita Kawakado, Go Makimoto, Masamoto Nakanishi, Shoichi Kuyama
Published 2021-06-01

Genetic polymorphism of rare mutations in Mycobacterium tuberculosis-infected patients in Delhi

by Himanshu Vashistha, Mahmud Hanif, Kamal Kishore Chopra, Divya Shrivastava, Ashwani Khanna
Published 2018-01-01

An open-label expanded access program of afatinib in EGFR tyrosine kinase inhibitor-naïve patients with locally advanced or metastatic non-small cell lung cancer harboring EGFR mut...

by Keunchil Park, Jin-Soo Kim, Joo-Hang Kim, Young-Chul Kim, Hoon-Gu Kim, Eun Kyung Cho, Jong-Youl Jin, Miyoung Kim, Angela Märten, Jin-Hyoung Kang
Published 2021-07-01

Clinical factors associated with treatment outcomes in EGFR mutant non-small cell lung cancer patients with brain metastases: a case-control observational study

by Yung-Hsuan Chen, Yen-Fu Chen, Chung-Yu Chen, Jin-Yuan Shih, Chong-Jen Yu
Published 2019-10-01

Correlation of TTF-1 immunoexpression and EGFR mutation spectrum in non–small cell lung carcinoma

by Tripti Nakra, Varsha Singh, Aruna Nambirajan, Prabhat Singh Malik, Anant Mohan, Deepali Jain
Published 2021-07-01

Heterogeneous Responses to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs) in Patients with Uncommon EGFR Mutations: New Insights and Future Perspectives...

by Alessandro Russo, Tindara Franchina, Giuseppina Ricciardi, Alessandra Battaglia, Maria Picciotto, Vincenzo Adamo
Published 2019-03-01

A rare epidermal growth factor receptor H773L/V774M compound mutation in advanced non‐small‐cell lung cancer with poor response to epidermal growth factor receptor tyrosine kinase...

by Lun‐Che Chen, Jin‐Yuan Shih, Chong‐Jen Yu, Ching‐Yao Yang
Published 2019-07-01